Former White House Council of Economic Advisers Chairman Tomas Philipson said on Newsmax Saturday that China’s tightening of rare earth mineral exports underscores why the White House is determined to move pharmaceutical manufacturing back to the United States.
China’s latest restrictions on rare earth exports are deepening trade tensions and prompting renewed discussion in Washington about supply-chain dependence on Beijing.
Philipson said on “Wake Up America Weekend” that China’s decision to expand controls over key rare earth elements and technologies highlights the urgency of repatriating vital industries such as pharmaceuticals.
Read more at Newsmax© 2025 Newsmax. All rights reserved.